KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares Repurchased
Ratios

Bio-Rad Laboratories (BIO) Receivables - Net (2016 - 2025)

Bio-Rad Laboratories (BIO) has disclosed Receivables - Net for 17 consecutive years, with $460.6 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net rose 1.79% to $460.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $460.6 million, a 1.79% increase, with the full-year FY2025 number at $460.6 million, up 1.79% from a year prior.
  • Receivables - Net was $460.6 million for Q4 2025 at Bio-Rad Laboratories, down from $464.7 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $498.3 million in Q1 2023 to a low of $399.3 million in Q2 2021.
  • A 5-year average of $452.5 million and a median of $455.0 million in 2023 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: grew 16.79% in 2022, then fell 10.73% in 2024.
  • Bio-Rad Laboratories' Receivables - Net stood at $423.5 million in 2021, then rose by 16.79% to $494.6 million in 2022, then decreased by 1.14% to $489.0 million in 2023, then decreased by 7.46% to $452.5 million in 2024, then grew by 1.79% to $460.6 million in 2025.
  • Per Business Quant, the three most recent readings for BIO's Receivables - Net are $460.6 million (Q4 2025), $464.7 million (Q3 2025), and $469.9 million (Q2 2025).